Exact Mass: 409.19362120000005

Exact Mass Matches: 409.19362120000005

Found 371 metabolites which its exact mass value is equals to given mass value 409.19362120000005, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

linustatin

2-methyl-2-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxy]propanenitrile

C16H27NO11 (409.15840319999995)

Ezetimibe

(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one

C24H21F2NO3 (409.14894200000003)

Ezetimibe is an anti-hyperlipidemic medication which is used to lower cholesterol levels. Specifically, it appears to bind to a critical mediator of cholesterol absorption, the Niemann-Pick C1-Like 1 (NPC1L1) protein on the gastrointestinal tract epithelial cells as well as in hepatocytes. D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D009676 - Noxae > D000963 - Antimetabolites Ezetimibe (SCH 58235) is a potent cholesterol absorption inhibitor. Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator.

Acidissiminol epoxide

N-[2-(4-{[(2E)-5-(3,3-dimethyloxiran-2-yl)-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidate

C25H31NO4 (409.22529660000004)

Acidissiminol epoxide is found in beverages. Acidissiminol epoxide is an alkaloid from fruits of Limonia acidissima (wood apple). Alkaloid from fruits of Limonia acidissima (wood apple). Acidissiminol epoxide is found in beverages and fruits.

Queuosine

2-amino-7-[(3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-({[(1S,4S,5R)-4,5-dihydroxycyclopent-2-en-1-yl]amino}methyl)-1H,4H,7H-pyrrolo[2,3-d]pyrimidin-4-one

C17H23N5O7 (409.1597408)

Queuosine is a modified nucleoside that is present in certain tRNAs in bacteria and eukaryotes. Originally identified in E. coli, queuosine was found to occupy the first anticodon position of tRNAs for histidine, aspartic acid, asparagine and tyrosine. The first anticodon position pairs with the third "wobble" position in codons, and queuosine improves accuracy of translation. Synthesis of queuosine begins with GTP. In bacteria, two classes of riboswitch are known to regulate genes that are involved in the synthesis or transport of pre-queuosine1, a precursor to queuosine: PreQ1-I riboswitches and PreQ1-II riboswitches (Wikipedia). Queuosine is a modified nucleoside that is present in certain tRNAs in bacteria and eukaryotes. Originally identified in E. coli, queuosine was found to occupy the first anticodon position of tRNAs for histidine, aspartic acid, asparagine and tyrosine. The first anticodon position pairs with the third "wobble" position in codons, and queuosine improves accuracy of translation. Synthesis of queuosine begins with GTP. In bacteria, two classes of riboswitch are known to regulate genes that are involved in the synthesis or transport of pre-queuosine1, a precursor to queuosine: PreQ1-I riboswitches and PreQ1-II riboswitches.

Q

(2R,3R,4S,5R)-2-[5-({[(1S,4S,5R)-4,5-dihydroxycyclopent-2-en-1-yl]amino}methyl)-4-hydroxy-2-imino-1H,2H,7H-pyrrolo[2,3-d]pyrimidin-7-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C17H23N5O7 (409.1597408)

Q is part of the Oxidative phosphorylation, Cardiac muscle contraction, Alzheimers disease, Parkinsons disease, and Huntingtons disease pathways. It is a substrate for: Cytochrome b-c1 complex subunit Rieske, mitochondrial.

Chondroitin D-glucuronate

(2S,3S,4S,5R,6R)-4,5-dihydroxy-6-{[(2R,3R,4R,5R,6R)-3-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy}-3-methyloxane-2-carboxylic acid

C16H27NO11 (409.15840319999995)

This compound belongs to the family of N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moeity in which the oxygen atom is replaced by an n-acyl group.

dermatan L-iduronate

(2R,3S,4S,5R,6R)-4,5-dihydroxy-6-{[(2R,3R,4R,5R,6R)-3-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy}-3-methyloxane-2-carboxylic acid

C16H27NO11 (409.15840319999995)

This compound belongs to the family of N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moeity in which the oxygen atom is replaced by an n-acyl group.

N-Carbamoyl glucuronide lorcaserin

(2R,3R,4R,5S)-6-(8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine-3-carbonyloxy)-3,4,5-trimethyloxane-2-carboxylic acid

C21H28ClNO5 (409.1655908000001)

N-Carbamoyl glucuronide lorcaserin is a metabolite of lorcaserin. Lorcaserin (APD-356, trade name Lorqess) is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States. On 16 September 2010, an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy. (Wikipedia)

2-({4-[5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl]-2,3-dihydro-1H-inden-1-yl}amino)ethan-1-ol

C23H27N3O4 (409.20014620000006)

3-N-Methylspiperone

8-[4-(4-fluorophenyl)-4-oxobutyl]-3-methyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one

C24H28FN3O2 (409.216544)

D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

Anthra(1,9-cd)pyrazol-6(2H)-one, 2-(2-((2-hydroxyethyl)amino)ethyl)-5-((2-((2-hydroxyethyl)amino)ethyl)amino)-

14-{2-[(2-hydroxyethyl)amino]ethyl}-10-({2-[(2-hydroxyethyl)amino]ethyl}amino)-14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2,4,6,9,11,13(16)-heptaen-8-one

C22H27N5O3 (409.2113792)

Acetylcorynoline

13,24-Dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-yl acetic acid

C23H23NO6 (409.1525298)

Butaperazine

1-{10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazin-2-yl}butan-1-one

C24H31N3OS (409.2187716)

N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

2-Ethyl-5,7-dimethyl-3-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)imidazo(4,5-b)pyridine

5-{2-[4-({2-ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-yl}methyl)phenyl]phenyl}-2H-1,2,3,4-tetrazole

C24H23N7 (409.2014838)

D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D057911 - Angiotensin Receptor Antagonists

2-Methyl-2-[4-[3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl]phenoxy]propanoic acid

2-methyl-2-[4-(3-{1-[(4-methylphenyl)methyl]-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl}propyl)phenoxy]propanoic acid

C23H27N3O4 (409.20014620000006)

Met-leu-phe

2-{2-[2-amino-4-(methylsulfanyl)butanamido]-4-methylpentanamido}-3-phenylpropanoic acid

C20H31N3O4S (409.20351660000006)

Naphthoquine

2-[(tert-butylamino)methyl]-4-[(7-chloroquinolin-4-yl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol

C24H28ClN3O (409.19207880000005)

Piclozotan

3-chloro-4-(4-{1,2,3,6-tetrahydro-[2,4-bipyridine]-1-yl}butyl)-4,5-dihydro-1,4-benzoxazepin-5-one

C23H24ClN3O2 (409.1556954)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist

(3R,4S)-1-(4-Fluorophenyl)-4-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-3-(4-hydroxyphenyl)azetidin-2-one

C24H21F2NO3 (409.14894200000003)

Trifluperidol

1-(4-fluorophenyl)-4-{4-hydroxy-4-[3-(trifluoromethyl)phenyl]piperidin-1-yl}butan-1-one

C22H23F4NO2 (409.1664826)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

Linustatin

2-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-methylpropanenitrile

C16H27NO11 (409.15840319999995)

Linustatin is a member of the class of compounds known as cyanogenic glycosides. Cyanogenic glycosides are glycosides in which the aglycone moiety contains a cyanide group. Linustatin is soluble (in water) and a very weakly acidic compound (based on its pKa). Linustatin can be found in a number of food items such as broad bean, plains prickly pear, shea tree, and longan, which makes linustatin a potential biomarker for the consumption of these food products.

Acetylcorynoline

[(1R,12S,13R)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-yl] acetate

C23H23NO6 (409.1525298)

Acetylcorynoline is a benzophenanthridine alkaloid. Acetylcorynoline is a natural product found in Corydalis bungeana, Corydalis remota, and other organisms with data available. Acetylcorynoline is the major alkaloid component derived from Corydalis bungeana, and has anti-inflammatory properties[1]. Acetylcorynoline is the major alkaloid component derived from Corydalis bungeana, and has anti-inflammatory properties[1].

[Chemical] Source; sea squirt H-antigen (limited periodate oxide)

Fluoxetine Succinamic Acid

C21H22F3NO4 (409.15008480000006)

CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 702

GNF-Pf-3985

C22H27N5OS (409.19362120000005)

Fructigenine B

C24H31N3O3 (409.23652960000004)

leptomaculin B

C19H27N3O7 (409.1848912)

14-Hydroxyisotylocrebrine

C24H27NO5 (409.18891320000006)

Neuro_000358

C24H27NO5 (409.18891320000006)

8-Ethoxy-3-oxo-1,2-dehydroretrorsine

C20H27NO8 (409.17365820000003)

Latrunculin C

C21H31NO5S (409.19228360000005)

haterumaimide P

C22H32ClNO4 (409.20197420000005)

brevicompanine H

C24H31N3O3 (409.23652960000004)

callosine

C21H31NO7 (409.2100416)

FT-0689398

C23H23NO6 (409.1525298)

SCHEMBL13222803

C24H27NO5 (409.18891320000006)

conithiaquinone B

C20H27NO6S (409.1559002000001)

Citropone B

C23H23NO6 (409.1525298)

Tyloindicine G

C24H27NO5 (409.18891320000006)

3-ethoxy-5-ethyl-4,5-dihydro-1,9-dimethoxy-4-oxodibenz(cd,f)indol-2-carboxylic acid ethyl ester

C24H27NO5 (409.18891320000006)

13a-hydroxytylophorine|13alpha-Hydroxytylophorine

C24H27NO5 (409.18891320000006)

C24H27NO5

C24H27NO5 (409.18891320000006)

(-)-ethyl (reframidin-15-yl)acetate

C23H23NO6 (409.1525298)

13a-Methyltylohirsutinidine

C24H27NO5 (409.18891320000006)

Tyloindicine D

C24H27NO5 (409.18891320000006)

2-amino-5-[(4,5-dihydroxy-cyclopent-2-enylamino)-methyl]-7-Beta-D-ribofuranosyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one

C17H23N5O7 (409.1597408)

Leu Tyr Thr

C20H31N3O6 (409.2212746)

Val Tyr Glu

C19H27N3O7 (409.1848912)

Pro Met Tyr

C19H27N3O5S (409.1671332)

Leu Thr Tyr

C20H31N3O6 (409.2212746)

Thr Tyr Leu

C20H31N3O6 (409.2212746)

Phe Asp Glu

C18H23N3O8 (409.1485078)

Glu Phe Asp

C18H23N3O8 (409.1485078)

Asn Asn Tyr

C17H23N5O7 (409.1597408)

Glu Tyr Val

C19H27N3O7 (409.1848912)

Ile Asp Tyr

C19H27N3O7 (409.1848912)

Ile Met Phe

C20H31N3O4S (409.20351660000006)

Tyr Val Glu

C19H27N3O7 (409.1848912)

Asp Glu Phe

C18H23N3O8 (409.1485078)

Tyr Ile Asp

C19H27N3O7 (409.1848912)

Pro Phe Phe

C23H27N3O4 (409.20014620000006)

Tyr Glu Val

C19H27N3O7 (409.1848912)

Val Glu Tyr

C19H27N3O7 (409.1848912)

Tyr Leu Thr

C20H31N3O6 (409.2212746)

Phe Ile Met

C20H31N3O4S (409.20351660000006)

Asp Phe Glu

C18H23N3O8 (409.1485078)

Met Phe Ile

C20H31N3O4S (409.20351660000006)

Asn Tyr Asn

C17H23N5O7 (409.1597408)

Tyr Thr Leu

C20H31N3O6 (409.2212746)

Tyr Asp Ile

C19H27N3O7 (409.1848912)

Phe Met Ile

C20H31N3O4S (409.20351660000006)

Phe Glu Asp

C18H23N3O8 (409.1485078)

Met Ile Phe

C20H31N3O4S (409.20351660000006)

Ile Tyr Asp

C19H27N3O7 (409.1848912)

Ile Phe Met

C20H31N3O4S (409.20351660000006)

Met Pro Tyr

C19H27N3O5S (409.1671332)

Phe Pro Phe

C23H27N3O4 (409.20014620000006)

Glu Asp Phe

C18H23N3O8 (409.1485078)

Glu Val Tyr

C19H27N3O7 (409.1848912)

Asp Ile Tyr

C19H27N3O7 (409.1848912)

Asp Tyr Ile

C19H27N3O7 (409.1848912)

Pro Tyr Met

C19H27N3O5S (409.1671332)

Hyaluronic acid

C16H27NO11 (409.15840319999995)

MLS002153367-01!Dehydroisoandrosterone 3-sulfate sodium salt dihydrate1099-87-2

[C19H30NaO6S]+ (409.16607000000005)

MLS001332601-01!Dehydroisoandrosterone 3-sulfate sodium salt dihydrate1099-87-2

C19H30NaO6S (409.16607000000005)

Ezetimibe

C24H21F2NO3 (409.14894200000003)

D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D009676 - Noxae > D000963 - Antimetabolites Ezetimibe (SCH 58235) is a potent cholesterol absorption inhibitor. Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator.

MMV007625

C22H27N5OS (409.19362120000005)

FR130739

C24H23N7 (409.2014838)

CONFIDENCE standard compound; INTERNAL_ID 1233; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4150; ORIGINAL_PRECURSOR_SCAN_NO 4149 CONFIDENCE standard compound; INTERNAL_ID 1233; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4178; ORIGINAL_PRECURSOR_SCAN_NO 4174 CONFIDENCE standard compound; INTERNAL_ID 1233; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4165; ORIGINAL_PRECURSOR_SCAN_NO 4164 CONFIDENCE standard compound; INTERNAL_ID 1233; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4170; ORIGINAL_PRECURSOR_SCAN_NO 4169 CONFIDENCE standard compound; INTERNAL_ID 1233; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4179; ORIGINAL_PRECURSOR_SCAN_NO 4177 CONFIDENCE standard compound; INTERNAL_ID 1233; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4181; ORIGINAL_PRECURSOR_SCAN_NO 4177 CONFIDENCE standard compound; INTERNAL_ID 1233; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8688; ORIGINAL_PRECURSOR_SCAN_NO 8686 CONFIDENCE standard compound; INTERNAL_ID 1233; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8687; ORIGINAL_PRECURSOR_SCAN_NO 8683 CONFIDENCE standard compound; INTERNAL_ID 1233; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8694; ORIGINAL_PRECURSOR_SCAN_NO 8692 CONFIDENCE standard compound; INTERNAL_ID 1233; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8713; ORIGINAL_PRECURSOR_SCAN_NO 8711 CONFIDENCE standard compound; INTERNAL_ID 1233; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8719; ORIGINAL_PRECURSOR_SCAN_NO 8716 CONFIDENCE standard compound; INTERNAL_ID 1233; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8718; ORIGINAL_PRECURSOR_SCAN_NO 8716

Cys Cys Gly Lys

(2S)-6-amino-2-{2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetamido}hexanoic acid

C14H27N5O5S2 (409.1453532)

Cys Cys Lys Gly

2-[(2S)-6-amino-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanamido]acetic acid

C14H27N5O5S2 (409.1453532)

Cys Gly Cys Lys

(2S)-6-amino-2-[(2R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanamido]hexanoic acid

C14H27N5O5S2 (409.1453532)

Cys Gly Lys Cys

(2R)-2-[(2S)-6-amino-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}hexanamido]-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)

Meptazinol glucuronide

C21H31NO7 (409.2100416)

Cys Lys Cys Gly

2-[(2R)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanamido]acetic acid

C14H27N5O5S2 (409.1453532)

Cys Lys Gly Cys

(2R)-2-{2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]acetamido}-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)

Gly Cys Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanoic acid

C14H27N5O5S2 (409.1453532)

Gly Cys Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)

Gly Gly Asn Tyr

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C17H23N5O7 (409.1597408)

Gly Gly Tyr Asn

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanoic acid

C17H23N5O7 (409.1597408)

Gly Lys Cys Cys

(2R)-2-[(2R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)

Gly Asn Gly Tyr

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]acetamido}-3-(4-hydroxyphenyl)propanoic acid

C17H23N5O7 (409.1597408)

Gly Asn Tyr Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]acetic acid

C17H23N5O7 (409.1597408)

Gly Tyr Gly Asn

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]acetamido}-3-carbamoylpropanoic acid

C17H23N5O7 (409.1597408)

Gly Tyr Asn Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]acetic acid

C17H23N5O7 (409.1597408)

Tyr Leu Asp

C19H27N3O7 (409.1848912)

Tyr Pro Met

C19H27N3O5S1 (409.1671332)

Asp Tyr Leu

C19H27N3O7 (409.1848912)

Asp Leu Tyr

C19H27N3O7 (409.1848912)

Met Phe Ile

C20H31N3O4S1 (409.20351660000006)

Pro Tyr Met

C19H27N3O5S1 (409.1671332)

Lys Cys Cys Gly

2-[(2R)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetic acid

C14H27N5O5S2 (409.1453532)

Lys Cys Gly Cys

(2R)-2-{2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)

Lys Gly Cys Cys

(2R)-2-[(2R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)

Met Pro Tyr

C19H27N3O5S1 (409.1671332)

Phe Phe Pro

C23H27N3O4 (409.20014620000006)

Leu Met Phe

C20H31N3O4S1 (409.20351660000006)

Asn Gly Gly Tyr

(2S)-2-(2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}acetamido)-3-(4-hydroxyphenyl)propanoic acid

C17H23N5O7 (409.1597408)

Asn Gly Tyr Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-(4-hydroxyphenyl)propanamido]acetic acid

C17H23N5O7 (409.1597408)

Met Leu Phe

C20H31N3O4S1 (409.20351660000006)

Leu Tyr Asp

C19H27N3O7 (409.1848912)

Asn Tyr Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]acetamido}acetic acid

C17H23N5O7 (409.1597408)

Phe Ile Met

C20H31N3O4S1 (409.20351660000006)

Leu Asp Tyr

C19H27N3O7 (409.1848912)

Tyr Met Pro

C19H27N3O5S1 (409.1671332)

Phe Met Ile

C20H31N3O4S1 (409.20351660000006)

Phe Met Leu

C20H31N3O4S1 (409.20351660000006)

Ile Phe Met

C20H31N3O4S1 (409.20351660000006)

Leu Phe Met

C20H31N3O4S1 (409.20351660000006)

Met Tyr Pro

C19H27N3O5S1 (409.1671332)

Tyr Asn Asn

C17H23N5O7 (409.1597408)

Met Ile Phe

C20H31N3O4S1 (409.20351660000006)

Ile Met Phe

C20H31N3O4S1 (409.20351660000006)

Pro Met Tyr

C19H27N3O5S1 (409.1671332)

Met Phe Leu

C20H31N3O4S1 (409.20351660000006)

Tyr Asp Leu

C19H27N3O7 (409.1848912)

Phe Leu Met

C20H31N3O4S1 (409.20351660000006)

Tyr Gly Gly Asn

(2S)-2-(2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}acetamido)-3-carbamoylpropanoic acid

C17H23N5O7 (409.1597408)

Tyr Gly Asn Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}-3-carbamoylpropanamido]acetic acid

C17H23N5O7 (409.1597408)

Tyr Asn Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]acetamido}acetic acid

C17H23N5O7 (409.1597408)

METHIONYL-LEUCYLPHENYLALANINE

C20H31N3O4S (409.20351660000006)

Queuosine

(7-(((4,5-cis-Dihydroxy-2-cyclopenten-1-yl)amino)methyl)-7-deazaguanosine)

C17H23N5O7 (409.1597408)

Severin

N-[2-(4-{[(2E)-5-(3,3-dimethyloxiran-2-yl)-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzamide

C25H31NO4 (409.22529660000004)

Thioridazine-d3 (hydrochloride)

C21H24ClD3N2S2 (409.149240734)

Poly(Styrene-Co-Divinylbenzene)

C24H27NO5 (409.18891320000006)

Boc-Tyr-D-Ala-Gly-OH

C19H27N3O7 (409.1848912)

Fmoc-Glu-Oall

C23H23NO6 (409.1525298)

Selprazine

C24H31N3O3 (409.23652960000004)

Z-Ala-Trp-OH

C22H23N3O5 (409.16376280000003)

Tamsulosin Sulfonic Acid

C20H27NO6S (409.1559002000001)

2-(METHYLAMINO)-2-PHENYLBUTYL 3,4,5-TRIMETHOXYBENZOATE HYDROCHLORIDE

C21H28ClNO5 (409.1655908000001)

Ezetimibe Tetrahydropyran Impurity

C24H21F2NO3 (409.14894200000003)

Fmoc-D-Hyp(tBu)-OH

C24H27NO5 (409.18891320000006)

Fmoc-Glu(Oall)-OH

C23H23NO6 (409.1525298)

(R)-Ezetimibe

C24H21F2NO3 (409.14894200000003)

Milipertine

C24H31N3O3 (409.23652960000004)

C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

Org 27569

C24H28ClN3O (409.19207880000005)

4-(N-Boc-phenylaminomethyl)benzeneboronic acid pinacol ester

C24H32BNO4 (409.2424262)

Fmoc-Hyp(tBu)-OH

C24H27NO5 (409.18891320000006)

1-tritylpyridin-1-ium,tetrafluoroborate

C24H20BF4N (409.1624838)

Eniclobrate

C24H24ClNO3 (409.14446240000007)

Prideperone

C23H24FN3O3 (409.1801606)

1H-Pyrrolo[2,3-b]pyridine-3-methanamine, 4-bromo-N,N-dimethyl-1-[tris(1-methylethyl)silyl]-

C19H32BrN3Si (409.1548732)

(R)-(-)-GLYCIDYLPHTHALIMIDE

C23H27N3O4 (409.20014620000006)

[2-(diethylcarbamoyl)-4-(2,4-difluorophenyl)phenyl] benzoate

C24H21F2NO3 (409.14894200000003)

Bunazosin Hydrochloride

C19H28ClN5O3 (409.1880568)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

BENZOSALICYLANILIDE GAMMA-PHENYLBUTYRATE

C27H23NO3 (409.16778480000005)

2-(METHYLAMINO)-2-PHENYLBUTYL 3,4,5-TRIMETHOXYBENZOATE

C21H28ClNO5 (409.1655908000001)

PHT-427

C20H31N3O2S2 (409.1857586)

PHT-247 is an inhibitor of the pleckstrin homology (PH) domain of Akt, and it is also an inhibitor of PDPK1 with Kis of 2.7 μM and 5.2 μM and for Akt and PDPK1, respectively.

Fenperate

C25H31NO4 (409.22529660000004)

[(2S)-2-(dibenzylamino)-3-phenylpropyl] methanesulfonate

C24H27NO3S (409.17115520000004)

Reboxetine mesylate

Reboxetine (mesylate)

C20H27NO6S (409.1559002000001)

D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators Reboxetine mesylate (FCE20124 mesylate) is a potent, selective, and specific noradrenaline reuptake inhibitor (NARI) for the research of depression. Reboxetine mesylate inhibits the uptake of norepinephrine, with a Ki of 8 nM[1].

(3S)-ent-Ezetimibe

C24H21F2NO3 (409.14894200000003)

ent-Ezetimibe

C24H21F2NO3 (409.14894200000003)

ent-Ezetimibe (ent-SCH 58235) is the RRS-enantiomer of Ezetimibe. Ezetimibe is a potent cholesterol absorption inhibitor.?Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent?Nrf2 activator[1].

C24H21F2NO3

C24H21F2NO3 (409.14894200000003)

Ezetimibe 3-Fluoro Impurity

C24H21F2NO3 (409.14894200000003)

9,9-(2,6-pyridinediyl)bis-9H-carbazole

C29H19N3 (409.15788940000004)

thiazol-5-ylmethyl ((2R,5R)-5-amino-1,6-diphenylhexan-2-yl)carbamate

C23H27N3O2S (409.18238820000005)

2(1H)-Isoquinolinecarboxylic acid, 8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-, 1,1-dimethylethyl ester

C22H23N3O3S (409.1460048)

N-kappa-Maleimidoundecanoic acid hydrazide trifluoroacetate

C15H25N3O3.C2HF3O2 (409.1824462)

Balovaptan

C22H24ClN5O (409.1669284)

C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D045283 - Natriuretic Agents > D065092 - Antidiuretic Hormone Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents

(R,E)-ethyl 5-([1,1-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate

C25H31NO4 (409.22529660000004)

(S)-N-Fmoc-Octylglycine

C25H31NO4 (409.22529660000004)

1,3-dimethyl-1,1,3,3-tetraphenyldisilazane

C26H27NSi2 (409.1681942)

5-[3-(tert-butyl)-1-(3-methylbenzyl)-1h-pyrazol-5-yl]-4-cyclohexyl-4h-1,2,4-triazole-3-thiol

C23H31N5S (409.23000460000003)

(R)-N-Fmoc-Octylglycine

C25H31NO4 (409.22529660000004)

Benexate

benzyl 2-[4-[(diaminomethylideneamino)methyl]cyclohexanecarbonyl]oxybenzoate

C23H27N3O4 (409.20014620000006)

C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

1-[2-[BIS(4-FLUOROPHENYL)METHOXY]ETHYL]-4-(PYRIDINYL)-PIPERAZINE

C24H25F2N3O (409.19655839999996)

Onalespib

C24H31N3O3 (409.23652960000004)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor

Cerlapirdine

C22H23N3O3S (409.1460048)

C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Cerlapirdine (SAM-531, PF-05212365) is a selective and potent full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine has the potential for researching the Alzheimer's disease[1].

Rabeximod

C22H24ClN5O (409.1669284)

COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Picarbutrazox

C20H23N7O3 (409.1862288)

trans-1-(4-Fluorophenyl)-3-(3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one

C24H21F2NO3 (409.14894200000003)

1-(4-Fluorophenyl)-3-(3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one

C24H21F2NO3 (409.14894200000003)

Methionyl-leucyl-phenylalanine

C20H31N3O4S (409.20351660000006)

4,5-Dimethyl-2-[[1-oxo-2-[4-(phenylmethyl)-1-pyridin-1-iumyl]ethyl]amino]-3-thiophenecarboxylic acid ethyl ester

C23H25N2O3S+ (409.15858000000003)

Pro-Phe-Phe

C23H27N3O4 (409.20014620000006)

Phe-Pro-Phe

C23H27N3O4 (409.20014620000006)

L-Methionyl-L-phenylalanyl-L-leucine

C20H31N3O4S (409.20351660000006)

FK-739 free acid

C24H23N7 (409.2014838)

N-[4-({[5-(Dimethylamino)-1-Naphthyl]sulfonyl}amino)butyl]-3-Sulfanylpropanamide

C19H27N3O3S2 (409.14937519999995)

3-[3-[[(2S)-2,3-dihydroxypropyl]amino]phenyl]-4-(5-fluoro-1-methylindol-3-yl)pyrrole-2,5-dione

C22H20FN3O4 (409.14377720000005)

Butaperazine

C24H31N3OS (409.2187716)

N-[4-(3,5-dimethylpyrazol-1-yl)phenyl]-1-[(2-methyl-1,3-thiazol-5-yl)methyl]piperidine-4-carboxamide

C22H27N5OS (409.19362120000005)

4-formyl-3-hydroxy-8a-methyl-6-(4-methylpent-3-enyl)-9,10-dioxo-1-propan-2-yl-8,10a-dihydro-5H-anthracen-2-olate

C25H29O5- (409.2014884)

4-formyl-3-hydroxy-6,8a-dimethyl-5-(3-methylbut-2-enyl)-9,10-dioxo-1-propan-2-yl-8,10a-dihydro-5H-anthracen-2-olate

C25H29O5- (409.2014884)

4-formyl-3-hydroxy-8a-methyl-7-(4-methylpent-3-enyl)-9,10-dioxo-1-propan-2-yl-8,10a-dihydro-5H-anthracen-2-olate

C25H29O5- (409.2014884)

4-formyl-3-hydroxy-7,8a-dimethyl-8-(3-methylbut-2-enyl)-9,10-dioxo-1-propan-2-yl-8,10a-dihydro-5H-anthracen-2-olate

C25H29O5- (409.2014884)

(2S,3S,6R)-6-(4-amino-2-oxopyrimidin-1-yl)-3-[[(3S)-3-azaniumyl-5-(diaminomethylideneazaniumyl)pentanoyl]amino]-3,6-dihydro-2H-pyran-2-carboxylate

C16H25N8O5+ (409.19478200000003)

2-amino-5-[[[(4S,5R)-4,5-dihydroxycyclopent-2-en-1-yl]amino]methyl]-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrrolo[2,3-d]pyrimidin-4-one

C17H23N5O7 (409.1597408)

(3R,4S)-1-(4-Fluorophenyl)-4-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-3-(4-hydroxyphenyl)azetidin-2-one

C24H21F2NO3 (409.14894200000003)

(3S,4aR,6aR,12aR,12bS)-3-Hydroxy-4,4,6a,12b-tetramethyl-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydrobenzo[f]pyrano[4,3-b]chromen-11(2H)-one

C25H31NO4 (409.22529660000004)

3-(6-Amino-5-cyano-3-isopropyl-1,4-dihydropyrano[2,3-c]pyrazol-4-yl)phenyl morpholine-4-carboxylate

C21H23N5O4 (409.17499580000003)

Leu-Asp-Tyr

C19H27N3O7 (409.1848912)

A tripeptide composed of L-leucine, L-aspartic acid and L-tyrosine joined in sequence by peptide linkages.

Ile-Phe-Met

C20H31N3O4S (409.20351660000006)

N-[2-(4-acetyl-1-piperazinyl)phenyl]-2-(5-methyl-2-propan-2-ylphenoxy)acetamide

C24H31N3O3 (409.23652960000004)

N-[1-[(cyclohexylamino)-oxomethyl]cyclohexyl]-N-(2-furanylmethyl)-2-pyridinecarboxamide

C24H31N3O3 (409.23652960000004)

2-[3-[(2-chloro-4-fluorophenyl)methyl]-2-oxo-1,3-diazinan-1-yl]-N-cyclooctylacetamide

C21H29ClFN3O2 (409.1932216)

3-cyclohexyl-2-hydrazinyl-7-(phenylmethyl)-6,8-dihydro-5H-pyrido[2,3]thieno[2,4-b]pyrimidin-4-one

C22H27N5OS (409.19362120000005)

1-[2-[4-(4-methoxyphenyl)piperazin-1-yl]ethyl]-N-methyl-3,4-dihydro-1H-isochromene-6-carboxamide

C24H31N3O3 (409.23652960000004)

N-[(4-fluorophenyl)methyl]-N-[(8-methyl-2-oxo-1H-quinolin-3-yl)methyl]-4-morpholinecarboxamide

C23H24FN3O3 (409.1801606)

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-methyl-2,5-dioxo-4-(2-phenylethyl)-1-imidazolidinyl]acetamide

C22H23N3O5 (409.16376280000003)

Tyr-Asp-Leu

C19H27N3O7 (409.1848912)

Glu-Asp-Phe

C18H23N3O8 (409.1485078)

Tyr-Asp-Ile

C19H27N3O7 (409.1848912)

Leu-Phe-Met

C20H31N3O4S (409.20351660000006)

Asp-Ile-Tyr

C19H27N3O7 (409.1848912)

Glu-Val-Tyr

C19H27N3O7 (409.1848912)

Met-Ile-Phe

C20H31N3O4S (409.20351660000006)

Tyr-Asn-Asn

C17H23N5O7 (409.1597408)

Phe-Met-Leu

C20H31N3O4S (409.20351660000006)

Asn-Tyr-Asn

C17H23N5O7 (409.1597408)

Asp-Leu-Tyr

C19H27N3O7 (409.1848912)

Asp-Phe-Glu

C18H23N3O8 (409.1485078)

(2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxy-3-sulfamoylphenyl)propan-2-aminium

C20H29N2O5S+ (409.17970840000004)

2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[(2-pyridin-2-ylacetyl)amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

(1R,5S)-7-[4-(3-pyridinyl)phenyl]-6-[[3-(trifluoromethyl)phenyl]methyl]-3,6-diazabicyclo[3.1.1]heptane

C24H22F3N3 (409.17657280000003)

2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

4-[4-[(1S,5R)-6-(1,3-benzodioxol-5-ylmethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

C26H23N3O2 (409.1790178)

2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]urea

C19H31N5O5 (409.2325076)

N-[3-(dimethylamino)propyl]-2-[(2R,3R,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide

C19H31N5O5 (409.2325076)

2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[(2-pyridin-2-ylacetyl)amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[(2-pyridin-2-ylacetyl)amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]urea

C19H31N5O5 (409.2325076)

1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]urea

C19H31N5O5 (409.2325076)

1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]urea

C19H31N5O5 (409.2325076)

N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(4-thiazolyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide

C19H27N3O5S (409.1671332)

N-[3-(dimethylamino)propyl]-2-[(2S,3R,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide

C19H31N5O5 (409.2325076)

N-[3-(dimethylamino)propyl]-2-[(2S,3R,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide

C19H31N5O5 (409.2325076)

N-[3-(dimethylamino)propyl]-2-[(2S,3S,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide

C19H31N5O5 (409.2325076)

N-[3-(dimethylamino)propyl]-2-[(2S,3S,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide

C19H31N5O5 (409.2325076)

(2S)-2-[(4R,5R)-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C20H31N3O4S (409.20351660000006)

(2S)-2-[(4S,5S)-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C20H31N3O4S (409.20351660000006)

(2S)-2-[(4S,5R)-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C20H31N3O4S (409.20351660000006)

2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]urea

C19H31N5O5 (409.2325076)

1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]urea

C19H31N5O5 (409.2325076)

N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(4-thiazolyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide

C19H27N3O5S (409.1671332)

N-[3-(dimethylamino)propyl]-2-[(2R,3S,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide

C19H31N5O5 (409.2325076)

N-[3-(dimethylamino)propyl]-2-[(2R,3S,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide

C19H31N5O5 (409.2325076)

(1R,2aS,8bS)-1-(hydroxymethyl)-4-[(4-methoxyphenyl)-oxomethyl]-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C23H27N3O4 (409.20014620000006)

(1R,5S)-7-(4-pyridin-4-ylphenyl)-6-[[2-(trifluoromethyl)phenyl]methyl]-3,6-diazabicyclo[3.1.1]heptane

C24H22F3N3 (409.17657280000003)

(3-fluorophenyl)-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanone

C23H24FN3O3 (409.1801606)

[(1S)-1-[(4-fluorophenyl)methyl]-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C24H28FN3O2 (409.216544)

(6S,7R,8S)-N-cyclopentyl-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C24H31N3O3 (409.23652960000004)

(6R,7R,8R)-N-cyclopentyl-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C24H31N3O3 (409.23652960000004)

(6R,7R,8R)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H24FN3O3 (409.1801606)

(6R,7R,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H24FN3O3 (409.1801606)

(2R,3S)-8-(2-benzofuranyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H27N3O4 (409.20014620000006)

(2R)-2-[(4S,5S)-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C20H31N3O4S (409.20351660000006)

(2R)-2-[(4R,5R)-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C20H31N3O4S (409.20351660000006)

(2R)-2-[(4S,5R)-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C20H31N3O4S (409.20351660000006)

(2S)-2-[(4R,5S)-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C20H31N3O4S (409.20351660000006)

(2R)-2-[(4R,5S)-8-[3-(dimethylamino)prop-1-ynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C20H31N3O4S (409.20351660000006)

2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide

C23H27N3O4 (409.20014620000006)

1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]urea

C19H31N5O5 (409.2325076)

1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]urea

C19H31N5O5 (409.2325076)

N-[3-(dimethylamino)propyl]-2-[(2R,3R,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide

C19H31N5O5 (409.2325076)

(2R,3R,4R)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-1-[2-(4-morpholinyl)-1-oxoethyl]-2-azetidinecarbonitrile

C23H24FN3O3 (409.1801606)

(1R,2aR,8bR)-1-(hydroxymethyl)-4-[(4-methoxyphenyl)-oxomethyl]-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C23H27N3O4 (409.20014620000006)

(1S,2aR,8bR)-1-(hydroxymethyl)-4-[(4-methoxyphenyl)-oxomethyl]-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C23H27N3O4 (409.20014620000006)

(1S,2aS,8bS)-1-(hydroxymethyl)-4-[(4-methoxyphenyl)-oxomethyl]-N-propan-2-yl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C23H27N3O4 (409.20014620000006)

(3-fluorophenyl)-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanone

C23H24FN3O3 (409.1801606)

(6R,7S,8S)-N-cyclopentyl-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C24H31N3O3 (409.23652960000004)

(6S,7R,8R)-N-cyclopentyl-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C24H31N3O3 (409.23652960000004)

(6R,7R,8S)-N-cyclopentyl-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C24H31N3O3 (409.23652960000004)

(6S,7S,8S)-N-cyclopentyl-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C24H31N3O3 (409.23652960000004)

(6R,7S,8R)-N-cyclopentyl-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C24H31N3O3 (409.23652960000004)

(6S,7R,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H24FN3O3 (409.1801606)

(6S,7S,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H24FN3O3 (409.1801606)

(6R,7S,8S)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H24FN3O3 (409.1801606)

(6S,7S,8R)-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H24FN3O3 (409.1801606)

Asp-Glu-Phe

C18H23N3O8 (409.1485078)

Asp-Tyr-Leu

C19H27N3O7 (409.1848912)

Glu-Phe-Asp

C18H23N3O8 (409.1485078)

Glu-Tyr-Val

C19H27N3O7 (409.1848912)

Ile-Met-Phe

C20H31N3O4S (409.20351660000006)

Met-Phe-Ile

C20H31N3O4S (409.20351660000006)

Met-Tyr-Pro

C19H27N3O5S (409.1671332)

Phe-Phe-Pro

C23H27N3O4 (409.20014620000006)

Pro-Tyr-Met

C19H27N3O5S (409.1671332)

Tyr-Ile-Asp

C19H27N3O7 (409.1848912)

Phe-Glu-Asp

C18H23N3O8 (409.1485078)

Val-Glu-Tyr

C19H27N3O7 (409.1848912)

Asp-Tyr-Ile

C19H27N3O7 (409.1848912)

Phe-Leu-Met

C20H31N3O4S (409.20351660000006)

Asn-Asn-Tyr

C17H23N5O7 (409.1597408)

Ile-Asp-Tyr

C19H27N3O7 (409.1848912)

Ile-Tyr-Asp

C19H27N3O7 (409.1848912)

Leu-Met-Phe

C20H31N3O4S (409.20351660000006)

Leu-Tyr-Asp

C19H27N3O7 (409.1848912)

Met-Pro-Tyr

C19H27N3O5S (409.1671332)

Phe-Asp-Glu

C18H23N3O8 (409.1485078)

Phe-Ile-Met

C20H31N3O4S (409.20351660000006)

Phe-Met-Ile

C20H31N3O4S (409.20351660000006)

Pro-Met-Tyr

C19H27N3O5S (409.1671332)

Tyr-Glu-Val

C19H27N3O7 (409.1848912)

Tyr-Leu-Asp

C19H27N3O7 (409.1848912)

Tyr-Met-Pro

C19H27N3O5S (409.1671332)

Tyr-Pro-Met

C19H27N3O5S (409.1671332)

Tyr-Val-Glu

C19H27N3O7 (409.1848912)

Val-Tyr-Glu

C19H27N3O7 (409.1848912)

3-((2E,6E)-9-((S)-3,3-Dimethyloxiran-2-yl)-3,7-dimethylnona-2,6-dien-1-yl)-4-hydroxy-6-(pyridin-3-yl)-2H-pyran-2-one

C25H31NO4 (409.22529660000004)

(2S)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxy-3-sulfamoylphenyl)propan-2-aminium

C20H29N2O5S+ (409.17970840000004)

(2S,3S,3aR,9bR)-3-(hydroxymethyl)-N-[(3-methoxyphenyl)methyl]-6-oxo-7-[(E)-prop-1-enyl]-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide

C23H27N3O4 (409.20014620000006)

(2R,3R,3aS,9bS)-3-(hydroxymethyl)-N-[(3-methoxyphenyl)methyl]-6-oxo-7-[(E)-prop-1-enyl]-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide

C23H27N3O4 (409.20014620000006)

4-(2,3-Dihydro-1,4-benzodioxine-6-carbonyl)-1-[2-(dimethylamino)ethyl]-5-pyridin-2-ylpyrrolidine-2,3-dione

C22H23N3O5 (409.16376280000003)

Fucalpha1-2FucalphaO[CH2]6NH2

C18H35NO9 (409.23117)

Dehydroisoandrosterone 3-sulfate sodium salt dihydrate

C19H30NaO6S+ (409.16607000000005)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-tridec-9-enoate

C18H36NO7P (409.22292760000005)

3-N-Methylspiperone

C24H28FN3O2 (409.216544)

D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

2-({4-[5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl]-2,3-dihydro-1H-inden-1-yl}amino)ethan-1-ol

C23H27N3O4 (409.20014620000006)

Met-Leu-Phe acetate salt

C20H31N3O4S (409.20351660000006)

N-Carbamoyl glucuronide lorcaserin

C21H28ClNO5 (409.1655908000001)

Dermatan L-iduronate

C16H27NO11 (409.15840319999995)

deacetylpyripyropene E

C25H31NO4 (409.22529660000004)

An organic heterotetracyclic compound that is (3S,4aR,6aR,12aR,12bS)-3-hydroxy-4,4,6a,12b-tetramethyl-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-benzo[f]pyrano[4,3-b]chromen-11-one substituted by a pyridin-3-yl group at position 9 (the 3S,4aR,6aR,12aR,12bS stereoisomer).

NA-Taurine 20:5(5Z,8Z,11Z,14Z,17Z)

C22H35NO4S (409.2286670000001)

LPC 10:1

C18H36NO7P (409.22292760000005)

LPC 8:3;O2

C16H28NO9P (409.15016080000004)

Met-Phe-Leu

C20H31N3O4S (409.20351660000006)

ST 18:3;O6;Gly

C20H27NO8 (409.17365820000003)

ST 19:2;O5;Gly

C21H31NO7 (409.2100416)

ST 23:6;O2;Gly

C25H31NO4 (409.22529660000004)

ST 18:4;O3;Tau

C20H27NO6S (409.1559002000001)

ST 19:3;O2;Tau

C21H31NO5S (409.19228360000005)

4-PPBP (maleate)

C25H31NO4 (409.22529660000004)

4-PPBP maleate is a potent σ 1 receptor ligand and agonist. 4-PPBP maleate is a non-competitive, selective NR1a/2B NMDA receptors (expressed in Xenopus oocytes) antagonist. 4-PPBP maleate provides neuroprotection[1][2][3].

Alogabat

C21H23N5O4 (409.17499580000003)

Alogabat (example 8) is a GABAA α5 receptor positive allosteric modulators (PAMs) (extracted from patent WO2018104419A1)[1].

FT113

C22H20FN3O4 (409.14377720000005)

FT113 is a potent and orally active fatty acid synthase (FASN) inhibitor, with an IC50 of 213 nM for full-length recombinant human FASN enzyme. In cell-based assay, FT113 blocks FASN activity in BT474 cells (IC50, 90 nM). FT113 shows anti-proliferative activity, and exhibits anti-cancer activity both in vitro and in vivo[1].